BIOHAVEN PHARMACEUTICAL

biohaven-pharmaceutical-logo

Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.

#SimilarOrganizations #People #Financial #Website #More

BIOHAVEN PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Neuroscience Pharmaceutical

Founded:
2013-01-01

Address:
New Haven, Connecticut, United States

Country:
United States

Website Url:
http://www.biohavenpharma.com

Total Employee:
1001+

Status:
Active

Total Funding:
443.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Font Awesome Mobile Non Scaleable Content IPv6 Google Maps ReCAPTCHA Cloudflare JS CDN JS


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.


Current Advisors List

declan-doogan_image

Declan Doogan Chairman of the Board of Directors @ Biohaven Pharmaceutical
Board_member

julia-gregory_image

Julia Gregory Member Board Of Directors, Audit Committee Chair @ Biohaven Pharmaceutical
Board_member
2017-08-01

john-w-childs_image

John W. Childs Board o Directors @ Biohaven Pharmaceutical
Board_member

vlad-coric_image

Vlad Coric Board o Directors @ Biohaven Pharmaceutical
Board_member

Current Employees Featured

rob-berman_image

Rob Berman
Rob Berman Executive Officer & Co-Founder, Special Projects & Medical Oversight @ Biohaven Pharmaceutical
Executive Officer & Co-Founder, Special Projects & Medical Oversight
2019-01-01

james-engelhart_image

James Engelhart
James Engelhart Chief Financial Officer @ Biohaven Pharmaceutical
Chief Financial Officer
2016-05-01

charles-conway_image

Charles Conway
Charles Conway Chief Scientific Officer @ Biohaven Pharmaceutical
Chief Scientific Officer
2017-01-01

william-bj-jones_image

William "BJ" Jones
William "BJ" Jones Chief Commercial Officer, Migraine & Common Diseases @ Biohaven Pharmaceutical
Chief Commercial Officer, Migraine & Common Diseases
2019-04-01

vlad-coric_image

Vlad Coric
Vlad Coric Chief Executive Officer @ Biohaven Pharmaceutical
Chief Executive Officer
2015-10-01

azim-munivar_image

Azim Munivar
Azim Munivar Medical Director @ Biohaven Pharmaceutical
Medical Director

elyse-stock_image

Elyse Stock
Elyse Stock Chief Medical Officer @ Biohaven Pharmaceutical
Chief Medical Officer
2019-01-01

robert-croop_image

Robert Croop
Robert Croop Chief Development Officer, Neurology @ Biohaven Pharmaceutical
Chief Development Officer, Neurology
2017-01-01

john-tilton_image

John Tilton
John Tilton Chief Commercial Officer @ Biohaven Pharmaceutical
Chief Commercial Officer
2016-04-01

cliff-bechtold_image

Cliff Bechtold
Cliff Bechtold Chief Operating Officer @ Biohaven Pharmaceutical
Chief Operating Officer
2017-10-01

Founder


rob-berman_image

Rob Berman

Stock Details


Company's stock symbol is NYSE:BHVN

Acquisitions List

Date Company Article Price
2021-01-07 Kleo Kleo acquired by Biohaven Pharmaceutical 20 M USD

Investors List

soros-fund-management_image

Soros Fund Management

Soros Fund Management investment in Post-IPO Equity - Biohaven Pharmaceutical

venrock_image

Venrock

Venrock investment in Venture Round - Biohaven Pharmaceutical

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Biohaven Pharmaceutical

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Venture Round - Biohaven Pharmaceutical

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Venture Round - Biohaven Pharmaceutical

aisling-capital_image

Aisling Capital

Aisling Capital investment in Venture Round - Biohaven Pharmaceutical

greg-bailey_image

Greg Bailey

Greg Bailey investment in Venture Round - Biohaven Pharmaceutical

knoll-capital-management_image

Knoll Capital Management

Knoll Capital Management investment in Venture Round - Biohaven Pharmaceutical

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Venture Round - Biohaven Pharmaceutical

litmore-capital_image

Litmore Capital

Litmore Capital investment in Venture Round - Biohaven Pharmaceutical

Investments List

Date Company Article Money raised
2021-03-01 Artizan Biosciences Biohaven Pharmaceutical investment in Series A - Artizan Biosciences 18.88 M USD
2018-11-14 Kleo Biohaven Pharmaceutical investment in Series B - Kleo 21 M USD
2016-09-01 Kleo Biohaven Pharmaceutical investment in Series A - Kleo N/A

Official Site Inspections

http://www.biohavenpharma.com Semrush global rank: 1.11 M Semrush visits lastest month: 29.03 K

  • Host name: ec2-3-130-137-99.us-east-2.compute.amazonaws.com
  • IP address: 3.130.137.99
  • Location: Columbus United States
  • Latitude: 39.9653
  • Longitude: -83.0235
  • Metro Code: 535
  • Timezone: America/New_York
  • Postal: 43215

Loading ...

More informations about "Biohaven Pharmaceutical"

Commitment to Patients, Winning with Science

Biohaven is dedicated to following science, continuously striving to evolve our approach to drug discovery and development to help people live healthier lives. To enhance our ability to deliver enduring value, we have combined internal …See details»

Biohaven Pharmaceutical

3 days ago Biohaven was founded in 2013 by a team of experienced biopharma professionals dedicated to rapid development and commercialization of innovative treatments for patients …See details»

Overview - Biohaven, Ltd.

Jan 13, 2025 Biohaven, Ltd. focuses on developing and commercializing innovative treatments for neurological, immunological, and oncological conditions.See details»

Biohaven Pharmaceuticals – Valuation, Revenue & Market Scope

Organization biohavenpharma.com Location New Haven , Connecticut , United States Industry BiotechSee details»

Biohaven Pharmaceutical Org Chart + Executive Team

The org chart of Biohaven Pharmaceutical contains its 120 main executives like Vlad Coric, Matthew Buten and John Tilton.See details»

Biohaven Pharmaceutical - Craft

See insights on Biohaven Pharmaceutical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Biohaven Pharmaceutical - VentureRadar

Biohaven is a clinical-stage biopharmaceutical company dedicated to advancing novel, life-changing therapies for neurological and neuropsychiatric diseases, including rare disorders. …See details»

Biohaven Pharmaceutical - Crunchbase Company …

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.See details»

Biohaven Pharmaceutical Holding Company Ltd.

Biohaven is a biopharmaceutical company focused on the development and commercialization of innovative best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases. …See details»

Biohaven Pharmaceutical Holding Company, Ltd Information

Biohaven Pharmaceutical Holding Company, Ltd is a Drug Manufacturing & Research, Biotechnology, and Neuroscience company located in New Haven, Connecticut with $155.6 …See details»

Biohaven - LinkedIn

Biohaven | 53,274 followers on LinkedIn. A modern pharmaceutical company guided by science and inspired to change the lives of people with unmet medical needs. | Biohaven is a uniquely …See details»

Biohaven Pharmaceuticals - Employees, Contact info, Overview

Apr 30, 2024 View info about Biohaven Pharmaceuticals (biohavenpharma.com). Biohaven Pharmaceuticals is a company located in New Haven, CT, United States. Find employees, …See details»

Biohaven Pharmaceutical - 2025 Company Profile & Team - Tracxn

Jul 15, 2025 Biohaven Pharmaceutical - Developer of therapies targeting neurological and neuropsychiatric diseases. Acquired by Pfizer. Raised a total funding of $84.1M over 3 rounds …See details»

Biohaven - Overview, News & Similar companies | ZoomInfo.com

View Biohaven (www.biohaven.com) location in Connecticut, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»

Biohaven Pharmaceuticals | Life Sciences PA

Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies for people with debilitating …See details»

Biohaven Company Profile | Management and Employees List

Find contact information for Biohaven. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Biohaven's email format.See details»

Biohaven Pharmaceutical Holding Company Ltd. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Biohaven Pharmaceutical Holding Company Ltd. of New Haven, CT. Get the latest business insights …See details»

Biohaven Pharmaceutical Holding Co. Ltd.:Company Profile

Discovery Company profile page for Biohaven Pharmaceutical Holding Co. Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

Jun 30, 2017 Biohaven Pharmaceutical Holding Company Ltd. is a United States-based commercial-stage biopharmaceutical company. The Company has a portfolio of therapies to …See details»

Biohaven Pharmaceuticals Company Overview, Contact Details ...

Learn more about Biohaven Pharmaceuticals's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

linkstock.net © 2022. All rights reserved